Truist Bumps Up Exponent's Price Target By 4%

  • Exponent Inc's EXPO price target has been raised to $120 (an upside of 12%) from $115 by Truist analyst Tobey Sommer after hosting the company's CEO and CFO for investor meetings.
  • The analyst maintained a Buy rating on the shares.
  • Sommer noted that the company's domestic court activity has continued to improve through the first quarter. He views Exponent's initial 2022 margin guidance as a "conservative benchmark."
  • The analyst expects the company to benefit from increased investment in infrastructure and energy transition measures.
  • Price Action: EXPO shares are trading higher by 1.99% at $107.68 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorNewsPrice TargetReiterationAnalyst RatingsBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!